YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells
-
Published:2023-11-29
Issue:12
Volume:43
Page:5485-5498
-
ISSN:0250-7005
-
Container-title:Anticancer Research
-
language:en
-
Short-container-title:Anticancer Res
Author:
LEE HSUN-HUA,HSIEH CHING-CHUAN,CHANG CHENG-CHIH,LIAO WAN-TING,CHI HSIANG-CHENG
Publisher
Anticancer Research USA Inc.
Subject
Cancer Research,Oncology,General Medicine